A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment

Drug and Alcohol Review

Volumn 31, Issue 4, 2012, Pages 483-491

  Holland, Richard ^a   Matheson, Catriona ^b   Anthony, Geraldine ^b   Roberts, Kennedy ^c   Priyardarshi, Saket ^c   Macrae, Ann ^d   Whitelaw, Eddie ^c   Appavoo, Sivaram ^e   Bond, Christine ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c Glasgow Addiction Services   (United Kingdom)

^d NHS HIGHLAND   (United Kingdom)

^e ROYAL CORNHILL HOSPITAL   (United Kingdom)

Author keywords

Adherence; Opiate maintenance treatment; RCT; Supervised consumption

Indexed keywords

METHADONE; NARCOTIC ANTAGONIST;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; PILOT PROJECTS; SCOTLAND; TREATMENT OUTCOME;

EID: 84861859426     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2011.00394.x     Document Type: Article

References (17)

1. Scottish Government. Review of methadone in drug treatment: prescribing information and practice. Edinburgh: The Scottish Government, 2007.
2. Matheson C, Bond CM, Tinelli M. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland. J Public Health (Oxf) 2007;29:350-7.
3. Independent Expert Working Group. Clinical guidelines on drug misuse and dependence update 2007: consultation draft June 2007. London: National Treatment Agency, 2007.
4. Advisory Council on the Misuse of Drugs. Reducing drug related deaths: a report of the Advisory Council on the Misuse of Drugs. London: The Stationery Office, 2000.
5. Departments of Health. Drug misuse and dependence: guidelines on clinical management. London: The Stationery Office, 1999.
6. Green H, James RA, Gilbert JD, Harpas P, Byard RW. Methadone maintenance programs-a two-edged sword? [Review][20 refs]. Am J Forensic Med Pathol 2000;21:359-61.
7. Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 1998;88:34-9.
8. Bell J, Shanahan M, Mutch C, etal. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. Addiction 2007;102:1899-907.
9. Weinrich M, Stuart M. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. [see comment]. JAMA 2000;283:1343-8.
10. Seymour A, Black M, Jay J, Cooper G, Weir C, Oliver J. The role of methadone in drug-related deaths in the west of Scotland. Addiction 2003;98:995-1002.
11. Strang J, Hall W, Hickman M, Bird SM. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): analyses using OD4 index in England and Scotland. BMJ 2010;341:c4851.
12. Cameron I, Naji S, Lind C, McGeganey N. A survey of NHS Services for opiate dependents in Scotland. Report to the Effective Interventions Unit. Edinburgh: Scottish Executive, 2001.
13. Marsden J, Gossop M, Stewart D, etal. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998;93:1857-67.
14. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
15. Anthony G, Matheson C, Holland R, etal. Methadone prescribing under supervised consumption on premises: A Scottish clinician's perspective on prescribing practice. Drug Alcohol Rev 2011; Online ahead of print. DOI: 10.1111/j.1465-3362.2011.00316.x.
16. Matheson C. Views of illicit drug users on their treatment and behaviour in Scottish community pharmacies: implications for the harm-reduction strategy. Health Educ J 1998;57:31-41.
17. Matheson C. Privacy and stigma in the pharmacy: illicit drug users' perspectives and implications for pharmacy practice. PJ 1998;260:639-41.